Literature DB >> 11956025

Mice lacking alpha(2)-macroglobulin show an increased host defense against Gram-negative bacterial sepsis, but are more susceptible to endotoxic shock.

Tino Hochepied1, Fred Van Leuven, Claude Libert.   

Abstract

The onset of an acute phase response is one of the initial steps in the defense against an infectious organism. Alpha(2)-macroglobulin (alpha(2)M), an acute phase protein in most mammalian species, is known to have a broad antiprotease activity, but it can also bind a number of growth factors, cytokines, ions and lipid factors. We have shown that alpha(2)M-deficient (MAM-/-) mice are more resistant to a lethal Gram-negative infection compared to control mice. This increased resistance was reflected in significantly higher body temperatures, compared to control mice, during the infection as well as in a prolonged and increased survival. Moreover, the clearance of bacteria in MAM-/- mice was significantly more efficient than in control mice. On the other hand, MAM-/- mice were more susceptible to endotoxin. An LD(100) challenge with endotoxin in MAM-/- mice was not lethal for control mice. Our data suggest that alpha(2)M plays a dual role during an acute phase response. In the establishment of a lethal Gram-negative infection, leading to sepsis and septic shock, it has a mediating role by hampering the efficient clearance of bacteria. During endotoxic shock, however, alpha(2)M has a rather protective function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956025

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  4 in total

Review 1.  Stress wars: the direct role of host and bacterial molecular chaperones in bacterial infection.

Authors:  Brian Henderson; Elaine Allan; Anthony R M Coates
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Molecular dissection of the human alpha2-macroglobulin subunit reveals domains with antagonistic activities in cell signaling.

Authors:  Elisabetta Mantuano; Gatambwa Mukandala; Xiaoqing Li; W Marie Campana; Steven L Gonias
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

3.  An acute phase protein ready to go therapeutic for sepsis.

Authors:  Sofie Vandevyver; Lien Dejager; Roosmarijn E Vandenbroucke; Claude Libert
Journal:  EMBO Mol Med       Date:  2014-01       Impact factor: 12.137

Review 4.  Alpha-2-Macroglobulin in Inflammation, Immunity and Infections.

Authors:  Jennifer Vandooren; Yoshifumi Itoh
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.